Renfree K J, Banovac K, Hornicek F J, Lebwohl N H, Villanueva P A, Nedd K J
Department of Orthopaedics and Rehabilitation, University of Miami School of Medicine, Florida.
Spine (Phila Pa 1976). 1994 Apr 1;19(7):740-6. doi: 10.1097/00007632-199404000-00002.
This was a blind, prospective study of the effect of sera from patients with spinal cord and head injuries on osteoblast proliferation.
The authors studied whether a humoral factor that stimulates the formation of heterotopic bone is released into the circulation after a neural injury.
Other authors have shown that a humoral osteoinductive factor may be released after head and spinal cord injuries.
Serum was obtained at certain times throughout the first 12 weeks post-injury and from control subjects. It was incubated with osteoblasts harvested from fetal rats, as well as with fibroblast controls.
There was a significant rise in serum mitogenic activity after injury in both groups. When patients that developed heterotopic ossification were compared to other patients and controls, no significant differences were seen.
This in vitro study fails to support a humoral mechanism for heterotopic ossification after spinal cord or brain injuries.
这是一项关于脊髓和头部损伤患者血清对成骨细胞增殖影响的前瞻性盲法研究。
作者研究神经损伤后是否有刺激异位骨形成的体液因子释放到循环中。
其他作者已表明头部和脊髓损伤后可能释放体液性骨诱导因子。
在损伤后的前12周内的特定时间从患者及对照受试者获取血清。将其与从胎鼠获取的成骨细胞以及成纤维细胞对照一同孵育。
两组患者损伤后血清促有丝分裂活性均显著升高。将发生异位骨化的患者与其他患者及对照进行比较时,未发现显著差异。
这项体外研究不支持脊髓或脑损伤后异位骨化的体液机制。